{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:25:31Z","timestamp":1776741931053,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1461100"],"award-info":[{"award-number":["23ZR1461100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005358","name":"Linyi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073813"],"award-info":[{"award-number":["82073813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304611"],"award-info":[{"award-number":["82304611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpha.2025.101415","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:03:48Z","timestamp":1753542228000},"page":"101415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rational design of a novel specific fluorescent substrate for monitoring hUGT1A4 activity and its application in identification of selective inhibitors"],"prefix":"10.1016","volume":"16","author":[{"given":"Ning","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101415_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389200003339171","article-title":"UDP-glucuronosyltransferases","volume":"1","author":"King","year":"2000","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.jpha.2025.101415_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425255.2014.876006","article-title":"The role of drug metabolizing enzymes in clearance","volume":"10","author":"Di","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpha.2025.101415_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/03602530903208561","article-title":"Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators","volume":"42","author":"Knights","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpha.2025.101415_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2133\/dmpk.DMPK-12-RV-096","article-title":"Function, genetic polymorphism, and transcriptional regulation of human UDP-glucuronosyltransferase (UGT) 1A1","volume":"28","author":"Sugatani","year":"2013","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.jpha.2025.101415_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1088458","article-title":"The uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism","volume":"12","author":"Liu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101415_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/mol.107.037952","article-title":"Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4","volume":"72","author":"Kubota","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101415_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.apsb.2018.09.005","article-title":"Recent progress and challenges in screening and characterization of UGT1A1 inhibitors","volume":"9","author":"Lv","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2025.101415_bib8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpha.2025.101415_bib9","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1210\/en.2013-2013","article-title":"Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability","volume":"155","author":"Wang","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpha.2025.101415_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/dmd.104.002303","article-title":"Metabolism of 26, 26, 26, 27, 27, 27-F6-1 alpha, 23S, 25-trihydroxyvitamin D3 by human UDP-glucuronosyltransferase 1A3","volume":"33","author":"Kasai","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpha.2025.101415_bib11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpba.2017.07.037","article-title":"N-glucuronidation catalyzed by UGT1A4 and UGT2B10 in human liver microsomes: assay optimization and substrate identification","volume":"145","author":"Lu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpha.2025.101415_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/clpt.1987.193","article-title":"Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans","volume":"42","author":"Cohen","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpha.2025.101415_bib13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/dmd.113.051565","article-title":"Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4","volume":"41","author":"Kato","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpha.2025.101415_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110505","article-title":"Species difference in toxicokinetics and safety assessment of senecionine N-oxide in a UDP-glucuronosyltransferase 1A4 humanized mouse model","volume":"380","author":"Chen","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpha.2025.101415_bib15","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1194\/jlr.M040519","article-title":"A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders","volume":"54","author":"Fang","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpha.2025.101415_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116490","article-title":"Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: implications for drug-drug interactions","volume":"466","author":"Lv","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101415_bib17","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/epi.12318","article-title":"Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains","volume":"54","author":"Ghosh","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpha.2025.101415_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2217\/pgs-2021-0051","article-title":"The pharmacogenetics of treatment with olanzapine","volume":"22","author":"Zubiaur","year":"2021","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpha.2025.101415_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/2193-1801-2-620","article-title":"Fulvestrant up regulates UGT1A4 and MRPs through ER\u03b1 and c-Myb pathways: a possible primary drug disposition mechanism","volume":"2","author":"Edavana","year":"2013","journal-title":"SpringerPlus"},{"key":"10.1016\/j.jpha.2025.101415_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168378","article-title":"Medicinal chemistry and NMR driven discovery of novel UDP-glucuronosyltransferase 1A inhibitors that overcome therapeutic resistance in cells","volume":"436","author":"Osborne","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jpha.2025.101415_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.phrs.2016.05.013","article-title":"Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction","volume":"110","author":"Xu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpha.2025.101415_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijbiomac.2021.03.073","article-title":"A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors","volume":"180","author":"Zhou","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jpha.2025.101415_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/395912","article-title":"Drug-drug interactions potential of icariin and its intestinal metabolites via inhibition of intestinal UDP-glucuronosyltransferases","volume":"2012","author":"Cao","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.jpha.2025.101415_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human udp-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpha.2025.101415_bib25","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1039\/C7CS00862G","article-title":"Recent progresses in small-molecule enzymatic fluorescent probes for cancer imaging","volume":"47","author":"Liu","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jpha.2025.101415_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116620","article-title":"High-throughput optical assays for sensing serine hydrolases in living systems and their applications","volume":"152","author":"Jin","year":"2022","journal-title":"Trac. Trends Anal. Chem."},{"key":"10.1016\/j.jpha.2025.101415_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fitote.2012.12.002","article-title":"Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation","volume":"84","author":"Lu","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jpha.2025.101415_bib28","doi-asserted-by":"crossref","first-page":"24566","DOI":"10.1002\/anie.202109479","article-title":"A molecular-splicing strategy for constructing a near-infrared fluorescent probe for UDP-glucuronosyltransferase 1A1","volume":"60","author":"Tian","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jpha.2025.101415_bib29","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1039\/c3cc38810g","article-title":"TokyoGreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1","volume":"49","author":"Terai","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jpha.2025.101415_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bios.2015.05.003","article-title":"An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications","volume":"72","author":"Lv","year":"2015","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jpha.2025.101415_bib31","doi-asserted-by":"crossref","first-page":"9664","DOI":"10.1021\/acs.jmedchem.7b01097","article-title":"A practical and high-affinity fluorescent probe for uridine diphosphate glucuronosyltransferase 1A1: a good surrogate for bilirubin","volume":"60","author":"Lv","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101415_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.133439","article-title":"A high-affinity fluorescent probe for human uridine-disphosphate glucuronosyltransferase 1A9 function monitoring under environmental pollutant exposure","volume":"465","author":"Miao","year":"2024","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.jpha.2025.101415_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/acs.molpharmaceut.7b00871","article-title":"Molecular docking-based design and development of a highly selective probe substrate for UDP-glucuronosyltransferase 1A10","volume":"15","author":"Juvonen","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpha.2025.101415_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00498250902745082","article-title":"Variation in glucuronidation of lamotrigine in human liver microsomes","volume":"39","author":"Argikar","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpha.2025.101415_bib35","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1038\/srep09627","article-title":"Identifying and applying a highly selective probe to simultaneously determine the O-glucuronidation activity of human UGT1A3 and UGT1A4","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101415_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/ja309346f","article-title":"Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1","volume":"135","author":"Silvers","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpha.2025.101415_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338305","article-title":"A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors","volume":"1153","author":"Zhou","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpha.2025.101415_bib38","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1124\/dmd.115.065680","article-title":"The polymorphic variant P24T of UDP-glucuronosyltransferase 1A4 and its unusual consequences","volume":"43","author":"Troberg","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpha.2025.101415_bib39","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1124\/dmd.108.021709","article-title":"Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes","volume":"36","author":"Kaivosaari","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpha.2025.101415_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-3565(24)29543-4","article-title":"Application of the relative activity factor approach in scaling from heterologously expressed cytochromes P450 to human liver microsomes: studies on amitriptyline as a model substrate","volume":"297","author":"Venkatakrishnan","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jpha.2025.101415_bib41","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/dmd.104.001206","article-title":"Identification of the rabbit liver udp-glucuronosyltransferase catalyzing the glucuronidation of 4-ethoxyphenylurea (dulcin)","volume":"32","author":"Uesawa","year":"2004","journal-title":"Drug Metab. Dispos."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:38:07Z","timestamp":1776371887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2095177925002321"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101415","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of a novel specific fluorescent substrate for monitoring hUGT1A4 activity and its application in identification of selective inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101415"}}